Metformin has been shown to protect the BBB in a mouse model of middle cerebral artery occlusion by downregulating the JNK pathway, reducing MMP-9 expression, and preserving the tight junction protein ZO-1, ultimately reducing infarct size [102]. This evidence concerns the gene MMP9 and medical procedure.